Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The optimal management of asymptomatic serological reactivation (ASR) in lupus nephritis (LN)
patients remained undefined. This project aims to investigate the impact of pre-emptive
treatment on disease relapse in LN patients who experienced ASR.